Free Trial
Guggenheim

Guggenheim Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Guggenheim. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Guggenheim's equity research team. MarketBeat is not affiliated with or endorsed by Guggenheim.

Average Return
00.00% 12-Month ROI
Total Ratings
981 Last 12 Months
Buy Ratings
816 Last 12 Months
Sell Ratings
13 Last 12 Months
Companies Covered
368 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
DraftKings Inc. stock logo
DKNG
DraftKings
$24.51
-4.0%
5/11/2026Lower Price Target$37.00 ➝ $35.00BuyView details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 5/11/2026
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
$24.86
-3.7%
5/11/2026Boost Price Target$23.00 ➝ $32.00BuyView details for Guggenheim rating of Jade Biosciences (NASDAQ:JBIO) on 5/11/2026
Coherus Oncology, Inc. stock logo
CHRS
Coherus Oncology
$1.95
+11.4%
5/11/2026 Initiated Coverage$12.00BuyView details for Guggenheim rating of Coherus Oncology (NASDAQ:CHRS) on 5/11/2026
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
$22.92
+1.5%
5/11/2026Initiated Coverage$42.00BuyView details for Guggenheim rating of Bicara Therapeutics (NASDAQ:BCAX) on 5/11/2026
Shake Shack, Inc. stock logo
SHAK
Shake Shack
$64.33
-8.3%
5/11/2026Lower Price Target$120.00 ➝ $100.00BuyView details for Guggenheim rating of Shake Shack (NYSE:SHAK) on 5/11/2026
Zevra Therapeutics, Inc. stock logo
ZVRA
Zevra Therapeutics
$10.80
-3.0%
5/8/2026Boost Price Target$23.00 ➝ $25.00BuyView details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 5/8/2026
Insmed, Inc. stock logo
INSM
Insmed
$103.89
+2.5%
5/8/2026Lower Price Target$230.00 ➝ $226.00BuyView details for Guggenheim rating of Insmed (NASDAQ:INSM) on 5/8/2026
Warner Music Group Corp. stock logo
WMG
Warner Music Group
$32.94
-1.3%
5/8/2026Boost Price Target$34.00 ➝ $36.00BuyView details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 5/8/2026
JFrog Ltd. stock logo
FROG
JFrog
$69.01
-2.2%
5/8/2026Boost Price Target$60.00 ➝ $80.00BuyView details for Guggenheim rating of JFrog (NASDAQ:FROG) on 5/8/2026
Akamai Technologies, Inc. stock logo
AKAM
Akamai Technologies
$153.01
+3.6%
5/8/2026Boost Price Target$133.00 ➝ $181.00BuyView details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 5/8/2026
argenex SE stock logo
ARGX
argenex
$813.28
+4.0%
5/8/2026Boost Price Target$1,120.00 ➝ $1,135.00BuyView details for Guggenheim rating of argenex (NASDAQ:ARGX) on 5/8/2026
Arhaus, Inc. stock logo
ARHS
Arhaus
$6.12
-6.0%
5/8/2026Lower Price Target$14.00 ➝ $12.00BuyView details for Guggenheim rating of Arhaus (NASDAQ:ARHS) on 5/8/2026
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
$14.23
+0.4%
5/8/2026Lower Price Target$68.00 ➝ $58.00BuyView details for Guggenheim rating of Janux Therapeutics (NASDAQ:JANX) on 5/8/2026
Planet Fitness, Inc. stock logo
PLNT
Planet Fitness
$48.45
+5.6%
5/8/2026Lower Price Target$126.00 ➝ $95.00BuyView details for Guggenheim rating of Planet Fitness (NYSE:PLNT) on 5/8/2026
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
$26.30
+0.7%
5/8/2026Lower Price Target$52.00 ➝ $43.00BuyView details for Guggenheim rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 5/8/2026
The Trade Desk stock logo
TTD
Trade Desk
$21.52
-6.8%
5/8/2026Lower Price Target$28.00 ➝ $25.00BuyView details for Guggenheim rating of Trade Desk (NASDAQ:TTD) on 5/8/2026
enGene Holdings Inc. stock logo
ENGN
enGene
$1.49
-0.7%
5/7/2026DowngradeBuyNeutralView details for Guggenheim rating of enGene (NASDAQ:ENGN) on 5/7/2026
Datadog, Inc. stock logo
DDOG
Datadog
$202.32
+1.1%
5/7/2026Boost Price Target$175.00 ➝ $225.00BuyView details for Guggenheim rating of Datadog (NASDAQ:DDOG) on 5/7/2026
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$310.75
-0.4%
5/7/2026Boost Price Target$410.00 ➝ $420.00BuyView details for Guggenheim rating of BeOne Medicines (NASDAQ:ONC) on 5/7/2026
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$144.15
+1.7%
5/7/2026Boost Price Target$205.00BuyView details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 5/7/2026
Portillo's Inc. stock logo
PTLO
Portillo's
$4.12
-4.2%
5/7/2026DowngradeBuyNeutralView details for Guggenheim rating of Portillo’s (NASDAQ:PTLO) on 5/7/2026
ARM Holdings PLC Sponsored ADR stock logo
ARM
ARM
$212.65
-0.3%
5/7/2026Boost Price Target$240.00 ➝ $255.00BuyView details for Guggenheim rating of ARM (NASDAQ:ARM) on 5/7/2026
The Walt Disney Company stock logo
DIS
Walt Disney
$104.48
-3.3%
5/7/2026Boost Price Target$115.00 ➝ $120.00BuyView details for Guggenheim rating of Walt Disney (NYSE:DIS) on 5/7/2026
The New York Times Company stock logo
NYT
New York Times
$77.34
-2.6%
5/7/2026Boost Price Target$63.00 ➝ $70.00NeutralView details for Guggenheim rating of New York Times (NYSE:NYT) on 5/7/2026
Warner Bros. Discovery, Inc. stock logo
WBD
Warner Bros. Discovery
$27.24
+0.5%
5/7/2026Reiterated RatingNeutralView details for Guggenheim rating of Warner Bros. Discovery (NASDAQ:WBD) on 5/7/2026
Sphere Entertainment Co. stock logo
SPHR
Sphere Entertainment
$127.06
-4.7%
5/6/2026Boost Price Target$160.00 ➝ $175.00BuyView details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 5/6/2026
Live Nation Entertainment, Inc. stock logo
LYV
Live Nation Entertainment
$163.05
-0.1%
5/6/2026Boost Price Target$192.00 ➝ $197.00BuyView details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 5/6/2026
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
$13.54
-2.0%
5/6/2026Reiterated Rating$21.00BuyView details for Guggenheim rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 5/6/2026
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$150.59
-1.1%
5/6/2026Reiterated Rating$175.00BuyView details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/6/2026
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
$56.21
-1.1%
5/5/2026Boost Price Target$55.00 ➝ $60.00BuyView details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 5/5/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
$13.17
-3.2%
5/5/2026Boost Price Target$11.00 ➝ $12.00BuyView details for Guggenheim rating of CryoPort (NASDAQ:CYRX) on 5/5/2026
Aclaris Therapeutics, Inc. stock logo
ACRS
Aclaris Therapeutics
$4.95
+0.4%
5/5/2026Initiated Coverage$12.00BuyView details for Guggenheim rating of Aclaris Therapeutics (NASDAQ:ACRS) on 5/5/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$965.85
+1.8%
5/5/2026Reiterated Rating$1,183.00BuyView details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 5/5/2026
Pinterest, Inc. stock logo
PINS
Pinterest
$20.75
-2.4%
5/5/2026Boost Price Target$21.00 ➝ $24.00BuyView details for Guggenheim rating of Pinterest (NYSE:PINS) on 5/5/2026
Paramount Skydance Corporation stock logo
PSKY
Paramount Skydance
$10.90
-1.7%
5/5/2026Lower Price Target$14.00 ➝ $12.00NeutralView details for Guggenheim rating of Paramount Skydance (NASDAQ:PSKY) on 5/5/2026
Sinclair, Inc. stock logo
SBGI
Sinclair
$14.27
-0.1%
5/5/2026Lower Price Target$20.00 ➝ $19.00BuyView details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 5/5/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$39.61
-2.8%
5/5/2026Lower Price Target$100.00 ➝ $70.00BuyView details for Guggenheim rating of GeneDx (NASDAQ:WGS) on 5/5/2026
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
$216.47
-0.4%
5/4/2026Boost Price Target$245.00 ➝ $260.00BuyView details for Guggenheim rating of Axsome Therapeutics (NASDAQ:AXSM) on 5/4/2026
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
$25.01
-0.7%
5/4/2026Boost Price Target$26.00 ➝ $31.00BuyView details for Guggenheim rating of Acadia Healthcare (NASDAQ:ACHC) on 5/4/2026
Celcuity, Inc. stock logo
CELC
Celcuity
$125.64
-4.1%
5/4/2026Boost Price Target$135.00 ➝ $165.00BuyView details for Guggenheim rating of Celcuity (NASDAQ:CELC) on 5/4/2026
Aclaris Therapeutics, Inc. stock logo
ACRS
Aclaris Therapeutics
$4.95
+0.4%
5/4/2026UpgradeStrong-BuyView details for Guggenheim rating of Aclaris Therapeutics (NASDAQ:ACRS) on 5/4/2026
Amgen Inc. stock logo
AMGN
Amgen
$329.59
-0.6%
5/4/2026Lower Price Target$351.00 ➝ $340.00NeutralView details for Guggenheim rating of Amgen (NASDAQ:AMGN) on 5/4/2026
Cigna Group stock logo
CI
Cigna Group
$288.86
+0.3%
5/4/2026Boost Price Target$334.00 ➝ $338.00BuyView details for Guggenheim rating of Cigna Group (NYSE:CI) on 5/4/2026
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
$20.36
+3.2%
5/4/2026Reiterated Rating$51.00BuyView details for Guggenheim rating of DBV Technologies (NASDAQ:DBVT) on 5/4/2026
EPAM Systems, Inc. stock logo
EPAM
EPAM Systems
$97.12
-2.1%
5/4/2026Lower Price Target$225.00 ➝ $200.00BuyView details for Guggenheim rating of EPAM Systems (NYSE:EPAM) on 5/4/2026
Wingstop Inc. stock logo
WING
Wingstop
$127.33
-1.8%
5/4/2026Lower Price Target$255.00 ➝ $215.00BuyView details for Guggenheim rating of Wingstop (NASDAQ:WING) on 5/4/2026
Roku, Inc. stock logo
ROKU
Roku
$128.07
-1.1%
5/1/2026Boost Price Target$130.00 ➝ $140.00BuyView details for Guggenheim rating of Roku (NASDAQ:ROKU) on 5/1/2026
Floor & Decor Holdings, Inc. stock logo
FND
Floor & Decor
$48.73
-5.8%
5/1/2026Lower Price Target$90.00 ➝ $65.00BuyView details for Guggenheim rating of Floor & Decor (NYSE:FND) on 5/1/2026
AbbVie Inc. stock logo
ABBV
AbbVie
$202.81
+0.6%
5/1/2026Reiterated Rating$249.00BuyView details for Guggenheim rating of AbbVie (NYSE:ABBV) on 5/1/2026
Chipotle Mexican Grill, Inc. stock logo
CMG
Chipotle Mexican Grill
$31.94
-1.7%
5/1/2026Lower Price Target$36.00 ➝ $35.00NeutralView details for Guggenheim rating of Chipotle Mexican Grill (NYSE:CMG) on 5/1/2026
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$712.77
-0.3%
5/1/2026Boost Price Target$975.00 ➝ $995.00BuyView details for Guggenheim rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 5/1/2026
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
$191.50
+0.6%
5/1/2026Lower Price Target$283.00 ➝ $252.00BuyView details for Guggenheim rating of Tenet Healthcare (NYSE:THC) on 5/1/2026
Wayfair Inc. stock logo
W
Wayfair
$61.34
-7.4%
5/1/2026Lower Price Target$120.00 ➝ $100.00BuyView details for Guggenheim rating of Wayfair (NYSE:W) on 5/1/2026
Biogen Inc. stock logo
BIIB
Biogen
$197.95
+2.3%
4/30/2026Boost Price Target$246.00 ➝ $260.00BuyView details for Guggenheim rating of Biogen (NASDAQ:BIIB) on 4/30/2026
Humana Inc. stock logo
HUM
Humana
$274.11
-0.3%
4/30/2026Boost Price Target$252.00 ➝ $269.00BuyView details for Guggenheim rating of Humana (NYSE:HUM) on 4/30/2026
Etsy Inc stock logo
ETSY
Etsy
$59.73
-7.2%
4/30/2026Boost Price Target$75.00 ➝ $85.00BuyView details for Guggenheim rating of Etsy (NYSE:ETSY) on 4/30/2026
Alphabet Inc. stock logo
GOOGL
Alphabet
$388.64
-3.0%
4/30/2026Reiterated Rating$375.00 ➝ $450.00BuyView details for Guggenheim rating of Alphabet (NASDAQ:GOOGL) on 4/30/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
$598.86
-1.8%
4/30/2026Lower Price Target$850.00 ➝ $800.00BuyView details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 4/30/2026
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$268.99
-1.4%
4/30/2026Reiterated Rating$300.00 ➝ $320.00BuyView details for Guggenheim rating of Amazon.com (NASDAQ:AMZN) on 4/30/2026
Cognizant Technology Solutions Corporation stock logo
CTSH
Cognizant Technology Solutions
$49.25
-4.7%
4/30/2026Lower Price Target$85.00 ➝ $80.00BuyView details for Guggenheim rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 4/30/2026
Everus Construction Group, Inc. stock logo
ECG
Everus Construction Group
$163.49
+0.2%
4/30/2026Upgrade$160.00NeutralBuyView details for Guggenheim rating of Everus Construction Group (NYSE:ECG) on 4/30/2026
Microsoft Corporation stock logo
MSFT
Microsoft
$412.66
-0.6%
4/30/2026Reiterated Rating$586.00BuyView details for Guggenheim rating of Microsoft (NASDAQ:MSFT) on 4/30/2026
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$168.23
-1.0%
4/29/2026Lower Price Target$238.00 ➝ $211.00BuyView details for Guggenheim rating of Universal Health Services (NYSE:UHS) on 4/29/2026
Starbucks Corporation stock logo
SBUX
Starbucks
$105.74
+0.8%
4/29/2026Reiterated Rating$95.00 ➝ $97.00NeutralView details for Guggenheim rating of Starbucks (NASDAQ:SBUX) on 4/29/2026
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
$11.04
+0.7%
4/29/2026Initiated Coverage$45.00BuyView details for Guggenheim rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 4/29/2026
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
$11.04
+0.7%
4/29/2026Initiated Coverage$45.00BuyView details for Guggenheim rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 4/29/2026
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
$7.69
-0.3%
4/29/2026Lower Price Target$27.00 ➝ $25.00BuyView details for Guggenheim rating of Sagimet Biosciences (NASDAQ:SGMT) on 4/29/2026
Spotify Technology stock logo
SPOT
Spotify Technology
$419.42
+0.4%
4/29/2026Lower Price Target$600.00 ➝ $565.00BuyView details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 4/29/2026
Sportradar Group AG stock logo
SRAD
Sportradar Group
$12.80
-1.8%
4/29/2026Lower Price Target$35.00 ➝ $30.00BuyView details for Guggenheim rating of Sportradar Group (NASDAQ:SRAD) on 4/29/2026
Neurogene Inc. stock logo
NGNE
Neurogene
$30.89
+0.4%
4/28/2026 Initiated Coverage$69.00BuyView details for Guggenheim rating of Neurogene (NASDAQ:NGNE) on 4/28/2026
MSLE
Satellos Bioscience
$7.30
-5.1%
4/28/2026Initiated Coverage$23.00BuyView details for Guggenheim rating of Satellos Bioscience (NASDAQ:MSLE) on 4/28/2026
Neurogene Inc. stock logo
NGNE
Neurogene
$30.89
+0.4%
4/28/2026 UpgradeStrong-BuyView details for Guggenheim rating of Neurogene (NASDAQ:NGNE) on 4/28/2026
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$65.68
+1.7%
4/27/2026Set Price Target$200.00BuyView details for Guggenheim rating of Oruka Therapeutics (NASDAQ:ORKA) on 4/27/2026
Ross Stores, Inc. stock logo
ROST
Ross Stores
$214.55
-5.0%
4/27/2026 Reiterated Rating$290.00BuyView details for Guggenheim rating of Ross Stores (NASDAQ:ROST) on 4/27/2026
Chewy stock logo
CHWY
Chewy
$22.48
-2.2%
4/27/2026Reiterated Rating$45.00BuyView details for Guggenheim rating of Chewy (NYSE:CHWY) on 4/27/2026
Equinix, Inc. stock logo
EQIX
Equinix
$1,086.22
+1.3%
4/27/2026Boost Price Target$985.00 ➝ $1,235.00BuyView details for Guggenheim rating of Equinix (NASDAQ:EQIX) on 4/27/2026
RH stock logo
RH
RH
$128.94
-3.7%
4/27/2026Reiterated Rating$200.00BuyView details for Guggenheim rating of RH (NYSE:RH) on 4/27/2026
Uber Technologies, Inc. stock logo
UBER
Uber Technologies
$75.98
+0.7%
4/27/2026Reiterated Rating$125.00BuyView details for Guggenheim rating of Uber Technologies (NYSE:UBER) on 4/27/2026
Warner Bros. Discovery, Inc. stock logo
WBD
Warner Bros. Discovery
$27.24
+0.5%
4/24/2026 Reiterated RatingBuyView details for Guggenheim rating of Warner Bros. Discovery (NASDAQ:WBD) on 4/24/2026
DraftKings Inc. stock logo
DKNG
DraftKings
$24.51
-4.0%
4/24/2026 Initiated CoverageNeutralBuyView details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 4/24/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
$381.58
+0.9%
4/24/2026Boost Price Target$396.00 ➝ $399.00BuyView details for Guggenheim rating of Elevance Health (NYSE:ELV) on 4/24/2026
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$43.51
+2.1%
4/24/2026Boost Price Target$54.00 ➝ $56.00BuyView details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 4/24/2026
Sirius XM Holdings Inc. stock logo
SIRI
Sirius XM
$26.78
-1.2%
4/24/2026Reiterated Rating$29.00 ➝ $34.00BuyView details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 4/24/2026
Shake Shack, Inc. stock logo
SHAK
Shake Shack
$64.33
-8.3%
4/24/2026Initiated Coverage$120.00BuyView details for Guggenheim rating of Shake Shack (NYSE:SHAK) on 4/24/2026
Shake Shack, Inc. stock logo
SHAK
Shake Shack
$64.33
-8.3%
4/24/2026Initiated Coverage$120.00BuyView details for Guggenheim rating of Shake Shack (NYSE:SHAK) on 4/24/2026
Tractor Supply Company stock logo
TSCO
Tractor Supply
$30.25
-1.3%
4/23/2026Reiterated Rating$65.00 ➝ $60.00BuyView details for Guggenheim rating of Tractor Supply (NASDAQ:TSCO) on 4/23/2026
GE Vernova Inc. stock logo
GEV
GE Vernova
$1,073.63
+3.2%
4/23/2026Boost Price Target$910.00 ➝ $1,300.00BuyView details for Guggenheim rating of GE Vernova (NYSE:GEV) on 4/23/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
$598.86
-1.8%
4/23/2026Reiterated Rating$850.00BuyView details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 4/23/2026
Microsoft Corporation stock logo
MSFT
Microsoft
$412.66
-0.6%
4/23/2026Reiterated Rating$586.00BuyView details for Guggenheim rating of Microsoft (NASDAQ:MSFT) on 4/23/2026
Cognizant Technology Solutions Corporation stock logo
CTSH
Cognizant Technology Solutions
$49.25
-4.7%
4/22/2026Lower Price Target$100.00 ➝ $85.00BuyView details for Guggenheim rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 4/22/2026
Danaher Corporation stock logo
DHR
Danaher
$166.46
-2.7%
4/22/2026Lower Price Target$275.00 ➝ $235.00BuyView details for Guggenheim rating of Danaher (NYSE:DHR) on 4/22/2026
Dynatrace, Inc. stock logo
DT
Dynatrace
$40.23
-1.2%
4/22/2026Lower Price Target$68.00 ➝ $60.00BuyView details for Guggenheim rating of Dynatrace (NYSE:DT) on 4/22/2026
Roku, Inc. stock logo
ROKU
Roku
$128.07
-1.1%
4/22/2026Boost Price Target$115.00 ➝ $130.00BuyView details for Guggenheim rating of Roku (NASDAQ:ROKU) on 4/22/2026
JFrog Ltd. stock logo
FROG
JFrog
$69.01
-2.2%
4/21/2026Reiterated Rating$60.00BuyView details for Guggenheim rating of JFrog (NASDAQ:FROG) on 4/21/2026
InflaRx N.V. stock logo
IFRX
InflaRx
$2.50
-3.1%
4/21/2026Reiterated Rating$14.00BuyView details for Guggenheim rating of InflaRx (NASDAQ:IFRX) on 4/21/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$965.85
+1.8%
4/21/2026Boost Price Target$1,163.00 ➝ $1,183.00BuyView details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 4/21/2026
The Madison Square Garden Company stock logo
MSGS
Madison Square Garden
$343.99
+4.2%
4/21/2026Boost Price Target$355.00 ➝ $401.00BuyView details for Guggenheim rating of Madison Square Garden (NYSE:MSGS) on 4/21/2026
Ulta Beauty Inc. stock logo
ULTA
Ulta Beauty
$511.98
-1.8%
4/20/2026 Initiated CoverageBuyView details for Guggenheim rating of Ulta Beauty (NASDAQ:ULTA) on 4/20/2026
Serve Robotics Inc. stock logo
SERV
Serve Robotics
$8.85
+0.9%
4/20/2026Initiated Coverage$13.00BuyView details for Guggenheim rating of Serve Robotics (NASDAQ:SERV) on 4/20/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$221.36
+0.0%
4/20/2026 Boost Price Target$244.00 ➝ $266.00BuyView details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 4/20/2026

MarketBeat's community ratings are surveys of what our community members think about Guggenheim and other research firms in the last 90 days. Vote "Outperform" if you believe Guggenheim's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Guggenheim's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
2.6out of 5 (last 90 days)
2.6 of 5 stars
OUTPERFORM VOTES
37 Believe will outperform the market
UNDERPERFORM VOTES
34 Believe will underperform the market

Guggenheim's equity research team has issued ratings on 365 companies across 16 sectors over the past 12 months, covered by 33 analysts. The Guggenheim analysts below are listed by number of ratings issued in the last year.

Guggenheim Stock Coverage by Sector

Guggenheim concentrates its research most heavily in Medical (47.3%), Computer and Technology (15.2%) and Retail/Wholesale (14.4%). The chart below shows how Guggenheim's 368 rated companies are distributed across all 16 sectors it covers.

Guggenheim - Frequently Asked Questions

Guggenheim's analysts currently have buy-equivalent ratings on 308 companies. Recent upgrades to buy include Aclaris Therapeutics, Everus Construction Group, Neurogene, Merus Labs International and Datadog.

Guggenheim's highest-rated analysts by MarketBeat's accuracy score include Seamus Fernandez, Joseph Osha and Vamil Divan. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 33 analysts at Guggenheim.

Guggenheim has the deepest coverage in Medical (47.3% of rated companies), Computer and Technology (15.2% of rated companies), Retail/Wholesale (14.4% of rated companies), Consumer Discretionary (10.9% of rated companies) and Energy (2.2% of rated companies).

Guggenheim issued 981 ratings over the last 12 months across 368 companies — an average of roughly 82 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Guggenheim analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Guggenheim uses Buy, Neutral, and Sell as their equivalents.